Tempest Therapeutics (TPST) Misses Q3 EPS by 79c
Tweet
Share
E-mailGet Alerts TPST Hot Sheet
Join SI Premium – FREE
Tempest Therapeutics (NASDAQ: TPST) reported Q3 EPS of ($0.79), $0.79 worse than the analyst estimate of $0.00.
For earnings history and earnings-related data on Tempest Therapeutics (TPST) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla readies August launch of CyberCab - The Information
- XP Inc. (XP) Tops Q2 EPS by 8c
- Duos Technologies Group, Inc. (DUOT) Tops Q2 EPS by 163c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
